Viveve Medical, Inc.
VIVE · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | -6.2% | 9.4% | -3.8% | – |
| Cost of Goods Sold | $1 | $2 | $1 | $2 |
| Gross Profit | $1 | $0 | $0 | -$0 |
| % Margin | 32.4% | 16.4% | 19.5% | -2.4% |
| R&D Expenses | $2 | $2 | $2 | $3 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $3 | $4 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | -$0 | -$0 |
| Operating Expenses | $5 | $5 | $6 | $6 |
| Operating Income | -$5 | -$5 | -$5 | -$6 |
| % Margin | -276.8% | -279.7% | -333.5% | -350.9% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$5 | -$5 | -$6 | -$6 |
| Tax Expense | $0 | $1 | $0 | $0 |
| Net Income | -$5 | -$6 | -$6 | -$6 |
| % Margin | -314.1% | -341.1% | -376.4% | -370.9% |
| EPS | -0.5 | -0.58 | -0.58 | -0.63 |
| % Growth | 13.8% | 0% | 7.9% | – |
| EPS Diluted | -0.5 | -0.58 | -0.58 | -0.63 |
| Weighted Avg Shares Out | 11 | 11 | 11 | 10 |
| Weighted Avg Shares Out Dil | 11 | 11 | 11 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$5 | -$5 | -$5 | -$6 |
| % Margin | -267.8% | -271.4% | -322.4% | -337.3% |